Nippon Express (Belgium) N.V./S.A. (Tsuyoshi Ogihara, President; hereinafter, “NX Belgium”), a Group company of Nippon Express Holdings, Inc. (Mitsuru Saito, President), has obtained Good Distribution Practice (GDP) certification effective December 21, 2021, for air and ground forwarding operations, inclusive of inventory control, at a facility in the cargo area of Brussels Airport, evidencing its compliance with GDP standards for the proper distribution of pharmaceuticals.
Belgium has become a hub for pharmaceutical manufacturing and development, hosting numerous global pharmaceutical companies as well as contract manufacturing organizations, vaccine manufacturers and biotechnology research laboratories.
NX Belgium has signed a business partnership agreement with Medexi, which specializes in pharmaceutical transport, and obtained GDP certification for operations at a Medexi-owned temperature-controlled 2,000m2 facility dedicated to pharmaceutical products that are capable of both refrigerated (2℃-8℃) and constant-temperature (15℃-25℃) storage.
Medexi’s pharmaceutical knowledge and advanced operational quality will be combined with the NX Group’s international temperature-controlled transport services and warehouse storage functions to provide customers with a pharmaceutical logistics platform.
The NX Group will continue stepping up its initiatives in the pharmaceutical industry, identified as a priority industry in the Group’s Business Plan, and globally enhancing and expanding its services to meet the increasingly sophisticated and diversified pharmaceutical transport needs of its customers.
